Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 4 completed trials

    Completion Rate
    100%(4/4)
    Active Trials
    2(33%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2
    1
    17%
    Phase 1
    4
    67%
    Phase 3
    1
    17%

    Phase Distribution

    4

    Early Stage

    1

    Mid Stage

    1

    Late Stage

    Phase Distribution6 total trials
    Phase 1Safety & dosage
    4(66.7%)
    Phase 2Efficacy & side effects
    1(16.7%)
    Phase 3Large-scale testing
    1(16.7%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    100.0%

    4 of 4 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    2

    trials recruiting

    Total Trials

    6

    all time

    Status Distribution
    Active(2)
    Completed(4)

    Detailed Status

    Completed4
    Recruiting2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    6
    Active
    2
    Success Rate
    100.0%
    Most Advanced
    Phase 3

    Trials by Phase

    Phase 14 (66.7%)
    Phase 21 (16.7%)
    Phase 31 (16.7%)

    Trials by Status

    recruiting233%
    completed467%

    Recent Activity

    2 active trials
    Showing 5 of 6
    recruitingphase_1

    A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

    NCT07231029
    recruitingphase_3

    A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

    NCT07285304
    completedphase_1

    A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects

    NCT07084961
    completedphase_2

    A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

    NCT06745518
    completedphase_1

    An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis

    NCT06849778
    View all 6 trials

    Clinical Trials (6)

    Showing 6 of 6 trials
    NCT07231029Phase 1

    A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

    Recruiting
    NCT07285304Phase 3

    A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

    Recruiting
    NCT07084961Phase 1

    A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects

    Completed
    NCT06745518Phase 2

    A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

    Completed
    NCT06849778Phase 1

    An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis

    Completed
    NCT04979572Phase 1

    A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)

    Completed

    All 6 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    6